Association of digoxin therapy with case fatality rate in acute pulmonary embolism

Author(s):  
Mehmet Baran Karataş ◽  
Nizamettin Selçuk Yelgeç ◽  
Yiğit Çanga ◽  
Ahmet Zengin ◽  
Ayşe Emre
2012 ◽  
Vol 125 (5) ◽  
pp. 478-484 ◽  
Author(s):  
Paul D. Stein ◽  
Fadi Matta ◽  
Daniel C. Keyes ◽  
Gary L. Willyerd

2004 ◽  
Vol 93 (9) ◽  
pp. 1197-1199 ◽  
Author(s):  
Paul D. Stein ◽  
Fadi Kayali ◽  
Ronald E. Olson

2012 ◽  
Vol 130 (6) ◽  
pp. 841-846 ◽  
Author(s):  
Paul D. Stein ◽  
Fadi Matta ◽  
Ahmed Alrifai ◽  
Akhil Rahman

2016 ◽  
Vol 115 (02) ◽  
pp. 399-405 ◽  
Author(s):  
Walter Ageno ◽  
Fulvio Pomero ◽  
Luigi Fenoglio ◽  
Alessandro Squizzato ◽  
Matteo Bonzini ◽  
...  

SummaryPulmonary embolism (PE) is a common disorder with high mortality and morbidity rates. However, population-based information on its incidence and prognosis remains limited. We conducted a large epidemiology study collecting data on hospitalisation for PE (from 2002 to 2012) in a population of about 13 million people in Northwestern Italy. Patients were identified using the ICD-9-CM codes: 415.11, 415.19; gender and age specific incidence rate of PE during the study period were estimated using the resident population for each year of the study. Furthermore, time trends in the in-hospital PE-related mortality and case fatality rate were calculated. Results were adjusted for possible confounders. A total of 60,853 patients (mean age 72.8 years, ± 14.1, 59.6 % females) with PE were included; the overall crude incidence rate for the entire study period was 55.4 and 40.6 events per year per 100,000 inhabitants for women and men, respectively (p < 0.001). However, this difference was completely lost after standardisation for age. The incidence of PE significantly increased in both genders during the study period. In-hospital case fatality rate significantly decreased throughout the study period (p < 0.001) in women (from 15.6 % to 10.2 %) and in men (from 17.6 % to 10.1 %). The observed decrease of the in-hospital case-fatality throughout the study period remained significant also after adjustment for possible confounders. In conclusion, time trends over an 11-year period show an increasing incidence of PE, but a significant reduction in mortality during hospitalisation. Reduction in the case fatality rate remained significant after adjustment for these possible confounders.Supplementary Material to this article is available online at www.thrombosis-online.com.


2019 ◽  
Vol 25 ◽  
pp. 107602961988802 ◽  
Author(s):  
Fulvio Pomero ◽  
Walter Ageno ◽  
Francesco Dentali ◽  
Luigi Fenoglio ◽  
Alessandro Squizzato ◽  
...  

In patients with venous thromboembolism (VTE), vena cava filters (VCFs) are currently only recommended when anticoagulant treatment is contraindicated or if VTE has recurred despite adequate anticoagulation. However, evidence on the efficacy of filter in patients with VTE is not compelling. We evaluated potential efficacy of VCF in reducing in-hospital mortality in a large population of patients presenting with a first episode of pulmonary embolism (PE). Patients were collected using regional hospital-discharge databases covering a population of more than 13 million of inhabitants in Northern Italy. For each year of observation, we calculated the proportion of cases with VCF among all PE incident cases. The temporal trend of VCF application during the study period was also derived. The effect of VCF use on in-hospital case-fatality rate was evaluated with a multivariate regression model and with the use of propensity score matching. During the study period (2002-2012), 60 813 patients were hospitalized for a first episode of acute PE. In-hospital case-fatality rate for PE was 13.3%. Vena cava filters were used in 745 (1.22%) patients. The annual use of VCF remained stable from 2002 to 2008, while it progressively decreased afterward. After adjustment for available confounders, case-fatality rate remained significantly lower in patients who received VCF compared to the one registered in patients who did not (odds ratio [OR] 0.46; 95% confidence interval [CI]: 0.34-0.62). Propensity score matching gave similar results (OR: 0.42; 95% CI: 0.30-0.61). Vena cava filters were infrequently used in patients with acute PE. Insertion of VCF appeared to sensibly reduce all-cause in-hospital mortality in this subgroup of patients.


Sign in / Sign up

Export Citation Format

Share Document